Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRAGMATIC: Dalteparin in Lung Cancer
NCT00519805Phase 3Unknown
- Sponsor
- Velindre University NHS Trust
- Start
- Aug 2007
- Primary completion
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dalteparin in lung cancer, sponsored by Velindre University NHS Trust. Status: unknown.
02
Drugs
dalteparin
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00519805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519805.